Human rhinovirus 3C protease inhibitors: recent developments
- 1 September 1998
- journal article
- Published by Informa Healthcare in Expert Opinion on Therapeutic Patents
- Vol. 8 (9) , 1151-1156
- https://doi.org/10.1517/13543776.8.9.1151
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Tripeptide Aldehyde Inhibitors of Human Rhinovirus 3C Protease: Design, Synthesis, Biological Evaluation, and Cocrystal Structure Solution of P1 Glutamine Isosteric ReplacementsJournal of Medicinal Chemistry, 1998
- Inhibition of human rhinovirus 3C protease by homophthalimidesBioorganic & Medicinal Chemistry Letters, 1997
- Small peptidic aldehyde inhibitors of human rhinovirus 3C proteaseBioorganic & Medicinal Chemistry Letters, 1996
- Design, Synthesis, and Evaluation of Nonpeptidic Inhibitors of Human Rhinovirus 3C ProteaseJournal of Medicinal Chemistry, 1996
- Glutamine-derived aldehydes for the inhibition of human rhinovirus 3C proteaseBioorganic & Medicinal Chemistry Letters, 1995
- Peptide Aldehyde Inhibitors of Hepatitis A Virus 3C ProteinaseBiochemistry, 1995
- Potent inhibitor of the human rhinovirus (HRV) 3C protease containing a backbone modified glutamineJournal of the Chemical Society, Perkin Transactions 1, 1995
- Structure-activity relationships for inhibition of papain by peptide Michael acceptorsJournal of Medicinal Chemistry, 1992
- PROTEOLYTIC PROCESSING OF PICORNAVIRAL POLYPROTEINAnnual Review of Microbiology, 1990
- Viral therapy: Prospects for protease inhibitorsJournal of Cellular Biochemistry, 1986